{"brief_title": "Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes", "brief_summary": "The purpose of this study is to assess the safety and effectiveness of vildagliptin, an unapproved drug, compared to metformin in lowering overall blood glucose levels in people with type 2 diabetes who have not been previously treated with drug therapy to lower their blood sugar.", "condition": ["Diabetes Mellitus, Type 2"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["vildagliptin", "Metformin Comparator"], "arm_group_label": ["Vildagliptin", "Metformin"], "other_name": ["LAF237A"], "criteria": "Inclusion Criteria: - Not currently on durg therapy for type 2 diabetes - Body mass index (BMI) in the range 22-45 - Blood glucose criteria must be met Exclusion Criteria: - Type 1 diabetes - Pregnancy or lactation - Evidence of serious diabetic complications - Evidence of serious cardiovascular conditions - Laboratory value abnormalities as defined by the protocol - Other protocol-defined exclusion criteria may apply", "gender": "All", "minimum_age": "18 Years", "maximum_age": "75 Years", "healthy_volunteers": "No", "keyword": "vildagliptin", "mesh_term": ["Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Vildagliptin", "Metformin"], "id": "NCT00099866"}